Thought Leadership & Research

Papers & Publications

We feel it’s important to maintain a high level of thought leadership in our field, providing insight and guidance to the health science domain in order to better serve the interests of our customers and, ultimately, patients.

Paper The Precompetitive Space for Drug or Vaccine Development: What Does it Look Like Now and What Could it Look Like in the Future?

How competing pharmaceutical organisations collaborate on shared drug development challenges without sacrificing competitive advantage.

DOI: 10.5863/1551-6776-28.5.465

Paper Tachykinin Receptors in GtoPdb v.2023.1

Tachykinin receptors in GtoPdb 2023.1 — NC-IUPHAR nomenclature, substance P, neurokinin A and B, and approved antagonists.

DOI: 10.2218/gtopdb/F62/2023.1

Paper Natural History and Real-World Data in Rare Diseases: Applications, Limitations, and Future Perspectives

Natural history and real-world data in rare disease drug development — applications, data quality, and AI and disease progression modelling.

DOI: 10.1002/jcph.2134

Paper Engaging student opinions on vaccine development innovation: Experiences from a “Shark Tank” project.

Student opinions on vaccine development innovation in a "Shark Tank" format, novel concept pitches, and AI contributions.

DOI: 10.1111/cts.13723

Paper Security in Aridhia’s Digital Research Environment: Five Safes

How the DRE implements the Five Safes Framework to balance research usability with healthcare data security in a cloud-native Trusted Research Environment.

1 2 3 4